Encyclopedia of Gerontology and Population Aging

Living Edition
| Editors: Danan Gu, Matthew E. Dupre

Cancer Screening

  • Haydeé Cristina Verduzco-Aguirre
  • Ana Patricia Navarrete-Reyes
  • Yanin Chavarri-Guerra
  • Enrique Soto-Perez-de-CelisEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-69892-2_759-1



Cancer screening refers to the identification of subclinical disease in a population through rapid and easy examinations and/or tests. The design and implementation of cancer screening requires the creation of mechanisms for systematic follow-up of individuals with abnormal results, a robust participation of the target population (at least 70%), and the infrastructure to offer the test and to further investigate and/or treat any abnormal findings (World Health Organization 2018; Maxim et al. 2014).


In 2018, the four most common malignancies among people aged ≥65 years worldwide were those of the lung, colon, prostate, and breast, all of which are susceptible to screening (Ferlay et al. 2018). Ideally, detecting (and treating) cancer at an early stage should lead to a reduction in mortality. However, most randomized controlled trials (RCT) of screening strategies have included...

This is a preview of subscription content, log in to check access.


  1. Baldrick E, Cresswell K, Ellis P et al (2019) Top ten research priorities for detecting cancer early. Lancet Public Health 4:e551.  https://doi.org/10.1016/S2468-2667(19)30185-9CrossRefGoogle Scholar
  2. Barré S, Massetti M, Leleu H et al (2017) Organised screening for cervical cancer in France: a cost- effectiveness assessment. BMJ Open 7:e014626.  https://doi.org/10.1136/bmjopen-2016-014626CrossRefGoogle Scholar
  3. De Koning H, Van der Alst C, Ten Haaf K et al (2018) Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial [PL02.05]. Presented at the IASLC 19th world conference on lung CancerGoogle Scholar
  4. Euhus DM, Addae JK, Snyder CF et al (2019) Change in health-related quality of life in older women after diagnosis of a small breast cancer. Cancer 125(11):1807–1814.  https://doi.org/10.1002/cncr.31993CrossRefGoogle Scholar
  5. Ferlay J, Ervik M, Lam F et al (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon. Available from: https://gco.iarc.fr/today. Accessed 31 Jan 19.
  6. Harris R, Leininger L (1995) Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 122:539–547.  https://doi.org/10.7326/0003-4819-122-7-199504010-00011.CrossRefGoogle Scholar
  7. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786.  https://doi.org/10.1016/S0140-6736(12)61611-0CrossRefGoogle Scholar
  8. Kim JJ, Campos NG, Sy S et al (2015) Inefficiencies and high-value improvements in the U.S. cervical cancer screening practice: a cost-effectiveness analysis. Ann Intern Med 163:589–597.  https://doi.org/10.7326/M15-0420CrossRefGoogle Scholar
  9. Kotwal AA, Schonberg MA (2017) Cancer screening in the elderly: a review of breast, colorectal, lung, and prostate cancer screening. Cancer 23:246–253.  https://doi.org/10.1097/PPO.0000000000000274CrossRefGoogle Scholar
  10. Lansdorp-Vogelaar I, Gulati R, Mariotto AB et al (2014) Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med 161:104–112.  https://doi.org/10.7326/M13-2867CrossRefGoogle Scholar
  11. Lauby-Secretan B, Vilahur N, Bianchini F et al (2018) The IARC perspective on colorectal cancer screening. N Engl J Med 378:1734–1740.  https://doi.org/10.1056/NEJMsr1714643CrossRefGoogle Scholar
  12. Lee SJ, Boscardin J, Stijacic-Cenzer I (2013) Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 36:e8441.  https://doi.org/10.1136/bmj.e8441CrossRefGoogle Scholar
  13. Lee CS, Moy L, Joe BN et al (2018) Screening for breast cancer in women age 75 years and older. Am J Roentgenol 210:256–263CrossRefGoogle Scholar
  14. Maxim LD, Niebo R, Utell MJ (2014) Screening tests: a review with examples. Inhal Toxicol 26:811–828.  https://doi.org/10.3109/08958378.2014.955932CrossRefGoogle Scholar
  15. Mazzone PJ, Silvestri GA, Patel S et al (2018) Screening for lung cancer: CHEST guideline and expert panel report. Chest 153:954–985.  https://doi.org/10.1016/j.chest.2018.01.016.CrossRefGoogle Scholar
  16. McKinney SM, Sieniek M, Godbole V et al (2020) International evaluation of an AI system for breast cancer screening. Nature 577:89–94.  https://doi.org/10.1038/s41586-019-1799-6CrossRefGoogle Scholar
  17. Melnikow J, Henderson JT, Burda BU et al (2018) Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 320:687–705.  https://doi.org/10.1001/jama.2018.10400CrossRefGoogle Scholar
  18. National Lung Cancer Screening Trial Research Team (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395–409.  https://doi.org/10.1056/NEJMoa1102873CrossRefGoogle Scholar
  19. Nelson HD, Fu R, Cantor A et al (2016) Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation. Ann Intern Med 164:244–255.  https://doi.org/10.7326/M15-0969CrossRefGoogle Scholar
  20. Pinsky PF, Miller E, Prorok P et al (2018) Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int.  https://doi.org/10.1111/bju.14580
  21. Piper MS, Maratt JK, Zikmund-Fisher BJ et al (2018) Patient attitudes toward individualized recommendations to stop low-value colorectal Cancer screening. JAMA Netw Open 1:e185461.  https://doi.org/10.1001/jamanetworkopen.2018.5461CrossRefGoogle Scholar
  22. Royce TJ, Hendrix LH, Stokes WA et al (2014) Cancer screening rates in individuals with different life expectancies. JAMA Intern Med 174(10):1558–1565.  https://doi.org/10.1001/jamainternmed.2014.3895CrossRefGoogle Scholar
  23. Schoenborn NL, Lee K, Pollack CE et al (2017) Older adults’ views and communication preferences about cancer screening cessation. JAMA Intern Med 177(8):1121–1128.  https://doi.org/10.1001/jamainternmed.2017.1778CrossRefGoogle Scholar
  24. Schonberg MA, Breslau ES, Hamel MB et al (2015) Colon Cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc 63:750–756.  https://doi.org/10.1111/jgs.13335CrossRefGoogle Scholar
  25. Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European randomised study of screening for prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035.  https://doi.org/10.1016/S0140-6736(14)60525-0CrossRefGoogle Scholar
  26. Sharma C, Deutsch I, Horowitz DP et al (2012) Patterns of care and treatment outcomes for elderly women with cervical cancer. Cancer 118:3618–3626.  https://doi.org/10.1002/cncr.26589CrossRefGoogle Scholar
  27. Stacey D, Légaré F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 4:CD001431.  https://doi.org/10.1002/14651858.CD001431.pub5.CrossRefGoogle Scholar
  28. Tang V, Boscardin WJ, Stijacic-Cenzer I et al (2015) Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials. BMJ 350:h1662.  https://doi.org/10.1136/bmj.h1662CrossRefGoogle Scholar
  29. Welch HG, Black WC (1997) Evaluating randomized trials of screening. J Gen Intern Med 12:118–124.  https://doi.org/10.1046/j.1525-1497.1997.00017.xCrossRefGoogle Scholar
  30. Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203–213.  https://doi.org/10.1056/NEJMoa1615869.CrossRefGoogle Scholar
  31. World Health Organization (2018) Early diagnosis and screening: screening. WHO, Geneva. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/screening/en/. Accessed 01 Jan 2020

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Haydeé Cristina Verduzco-Aguirre
    • 1
  • Ana Patricia Navarrete-Reyes
    • 2
  • Yanin Chavarri-Guerra
    • 1
  • Enrique Soto-Perez-de-Celis
    • 2
    Email author
  1. 1.Department of Hemato-OncologyInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico CityMexico
  2. 2.Department of GeriatricsInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico CityMexico

Section editors and affiliations

  • Paul Hofman
    • 1
  • Rabia Boulahssass
    • 2
  1. 1.Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), Laboratoire de Pathologie Clinique et Expérimentale et BiobanqueHôpital PasteurNiceFrance
  2. 2.Geriatric Coordination Unit for Geriatric Oncology (UCOG) PACA Est Nice University HospitalUniversité Côte d’AzurNiceFrance